5 results
• To estimate the difference in the efficacy and safety of RAD001 10 mg p.o. daily dose in combination with bevacizumab 10 mg/kg administered intravenously every two weeks for first-line treatment of patients with metastatic carcinoma of the kidney…
This study will evaluate the antitumor activity of RAD001 versus placebo in patients with subependymal giant cell astrocytomas (SEGA) associated with Tuberous Sclerosis Complex (TSC).
This study will evaluate the antitumor activity of RAD001 versus placebo in patients with angiomyolipoma associated with either TSC or LAM.
To demonstrate that Nanocort is safe and effectively reduces the inflammatory signs and symptoms of active GO.
Primary: to assess the efficacy and safety of autologous epidermal cell suspension grafting using the ReCell kit after CO2 laser abrasion with superficial full surface ablation, fractional laser treatment and conventional (deep) full surface CO2…